Gene Symbol | Probe Identifier | Clinical Cohort | P-value | Level of Clinical Cohort | Hazard Ratio1 | Relevant literature references |
---|---|---|---|---|---|---|
Prkcb 2 | 207957_s_at | Gender | <.0001 | Male | 0.36 (0.24-0.55) | [28]G |
 |  |  |  | Female | 1.27 (0.84-1.93) |  |
 |  | Therapy | 0.0006 | None | 0.38 (0.25-0.60) |  |
 |  |  |  | CRnoT | 0.51 (0.36-0.73) |  |
 |  |  |  | R | 0.64 (0.46-0.88) |  |
 |  |  |  | CRT | 0.71 (0.44-1.13) |  |
 |  |  |  | Other | 0.75 (0.43-1.32) |  |
Sox10 | 209843_s_at | Race | 0.0018 | White | 0.55 (0.44-0.68) | [10]G |
 |  |  |  | Other | 1.08 (0.72-1.62) |  |
Egfr | 211607_x_at | Gender | <.0001 | Male | 0.60 (0.50-0.72) | [24]G |
 |  |  |  | Female | 0.88 (0.74-1.04) |  |
Chi3l1 | 209396_s_at | Therapy | 0.0006 | CRT | 1.27 (0.96-1.70) | [70]G |
 |  |  |  | R | 1.28 (1.07-1.52) |  |
 |  |  |  | Other | 1.31 (1.04-1.66) |  |
 |  |  |  | CRnoT | 1.53 (1.31-1.79) |  |
 |  |  |  | None | 2.42 (1.56-3.75) |  |
C2 | 203052_at | Gender | 0.0033 | Female | 1.30 (1.03-1.65) | n/a |
 |  |  |  | Male | 1.93 (1.56-2.39) |  |
Prkcb | 209685_s_at | Gender | <.0001 | Female | 1.31 (0.79-2.14) | [28]G |
 |  |  |  | Male | 5.21 (3.16-8.61) |  |